Navigation Links
Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania
Date:8/29/2008

Joint Effort with Baylor International Pediatric AIDS Initiative Will

Improve Access to Health Care for Children with HIV/AIDS

WASHINGTON, Aug. 29 /PRNewswire-FirstCall/ -- The Abbott Fund joined representatives from the U.S. government, Baylor College of Medicine, the government of Tanzania and other partners today at a U.S. President's Emergency Plan for AIDS Relief (PEPFAR) news conference to announce a joint effort to improve care and treatment for children with HIV/AIDS in Tanzania. The Abbott Fund announced it is supporting the construction of the first pediatric HIV/AIDS clinic in the country, in the Mbeya region of Tanzania.

"Building this clinic represents an important expansion in Abbott's commitment to improving access to care for children in the developing world during the last decade," said Catherine V. Babington, president, the Abbott Fund. "It fulfills a critical need in Tanzania, where we have been improving health systems not only for people with HIV, but also for those with other chronic health issues as well." The new clinic will bring the first pediatricians trained in the special needs of children with HIV to Mbeya.

It is estimated that there are currently more than 150,000 (UNAIDS 2008) children in Tanzania living with HIV/AIDS and in need of treatment and care. Mbeya has the second highest rate of HIV in the country, with a prevalence rate of more than 13 percent among a population of more than two million. According to the National AIDS Control Project (NACP), last year only 2,280 children were registered to receive care with half receiving antiretroviral (ARV) therapy. In contrast, almost 16,000 adults in Mbeya are on ARV therapy.

"While we are making progress in enrolling adults into HIV care and treatment, our services for children have severely lagged behind due to lack of trained physicians and other necessary resources," said Eleuter Samky, M.D., medical superintendent, Mbeya Referral Hospit
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2008)... Open enrollment is now ha... cover expenses not covered by Medicare, and may a...ny consumers are now shopping online for instant q... Fort Collins, CO (PRWEB) November 21, 2008 -- Med...nt for Medicare Supplement plans . Medicare Adva...
(Date:11/21/2008)...inding may lead to new therapies for preterm labor... Researchers say they,ve found the switch that act...childbirth, a finding that may lead to therapies f...normally binds the protein IP on the surface of th...inactive during pregnancy. , But researchers f...
(Date:11/21/2008)..., TALLAHASSEE, Fla. -- A Florida State University... Wang has discovered an important new layer of reg...ad to a greater understanding of the way cancer be...al sciences at the College of Medicine, said the f...se cancer and could lead to the design of new drug...
(Date:11/21/2008)...OVELAND, Colo., Nov. 21 ...ed it will present at the New York Society of,Sec...Pharma Conference on,December 2, 2008 at 1177 Ave...he presentation is scheduled to begin at 9:35 a.m....be available via live webcast and for two weeks,f...
Breaking Medicine News(10 mins):Health News:MediGap Advisors Announces Open Enrollment for Medicare Supplement Plans 2
... a half months after his sexual organ was complete... to lead a normal life again after a Delhi hospita...The unmarried man from Uttar Pradesh underwent a s...he Sir Ganga Rama Hospital (SGRH), a leading priva...
...pproach to drug delivery has been achieved. This i...rong and stable glass made from organic material....he journal Science has reported the advanced proce...nsin-Madison and the National Institute of Standar...
...sh scientist was a consultant for a chemical compa...ossibility of developing cancer in the industry.//...demiologist, who died last year was known for havi... blamed in 1800 for having received $1,500 as dail...
...ian parliamentarians will attend a two-day confere...ple's elected representatives in combating the dis..., a worldwide network of individual parliamentaria...al assembly of Punjab (Pakistan), Pakistan Nationa...
Other Medicine News:Health News:Delhi Hospital Reattaches Amputated Penis 2Health News:Drugs Delivery Revolutionized by Extremely Stable Glass 2
(Date:11/20/2008)...w Jersey American Water has lifted the precaution...following municipalities in Middlesex, Somerset an... , , Dunellen , Edison , ...nfield , , , , Somerset County , ..., Green Brook , Hillsborough , ...
(Date:11/20/2008)...SE III TRIAL SHOW SIGNIFICANT, DECREASES IN P..., IN, FIBROMYALGIA PAT...ium, Nov. 20 /PRNewswire-FirstCall/,-- Jazz Pharm...xt Brussels: UCB),announced today positive prelim...e III pivotal clinical trials of sodium oxybate (J...
(Date:11/20/2008)...lk. It does a body good. And,now it,s doing it ev...,research, scientists at OncoNutrition(TM) have di...ate the body,s own production of antioxidants. , ...to:, http://www.prnewswire.com/mnr/eqwestgroup/361...apies, the chief scientist, Dr. David,Tsai, disco...
(Date:11/20/2008)...ll/ -- Duska Therapeutics,Inc., (OTC Bulletin Bo...its,pivotal Phase 3 ATPace clinical trial protoco...(SPA) procedure with the U.S. Food and Drug Admini...greement with the FDA, Duska intends to initiate a...olled and randomized Phase 3,clinical trial with ...
Breaking Medicine Technology:New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 1Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 2Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 3Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 4Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 5Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 6Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 7Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 8SEIU DVD Exposes How McCain Care Leaves Seniors Behind 27197 1SEIU DVD Exposes How McCain Care Leaves Seniors Behind 27197 2PreMD Inc Completes Secured Debenture Financing 27193 1PreMD Inc Completes Secured Debenture Financing 27193 2Thousands of Public Health Experts to Address Leading Issues at APHA Annual Meeting Oct 25 29 27190 1Thousands of Public Health Experts to Address Leading Issues at APHA Annual Meeting Oct 25 29 27190 2
....--(BUSINESS WIRE)--Apr 19, 2007 - Othera Pharmace...a, Professor of,Pharmacology and Executive Vice Pr...h Institute at Albany College of Pharmacy,will pr...antithrombotic effect of Othera,s lead compound, O...ms from previous ocular,studies on OT-551 eye drop...
...OAKS, Calif.--(BUSINESS WIRE)--Apr 19, 2007 - Amge...e "145 study", a,randomized, double-blind, placebo...R) (darbepoetin alfa) in 600 previously untreated,...er (SCLC),receiving platinum-containing chemothera...icant difference in risk of death (overall,surviva...
Other Medicine Technology:Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 2Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 3Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7
...a non-absorbable, lightweight, pre-formed, three-d...ofilament polypropylene with multiple protruding m...nforms to the defect, stays in place, sutures easi...procedure. The soft, flexible mesh minimizes irria...
...aroscopic inguinal hernia repair and urethral susp... biomaterial that enables rapid fixation by tissue...es the answer to the most demanding hernia and sof...inert and conformable ePTFE, GORE MYCROMESH Biomat...
...omaterial is the first hernia repair material with...l operative contamination of the material. This ad...l preservative agents, silver carbonate and chlorh...colonization on the patch for up to 10 days post-i...
...ided ePTFE mesh designed for ventral hernia repair... to minimize visceral attachment to the prosthesis...signed to promote tissue growth. This ingrowth sid...ich is nearly equivalent to polypropylene mesh. Ba...
Medicine Products: